Hyperactivity of the hypothalamus-pituitary-adrenal axis in lipopolysaccharide-induced neurodevelopmental model of schizophrenia in rats: effects of antipsychotic drugs.
Basta-Kaim
Agnieszka
A
Department of Experimental Neuroendocrinology, Institute of Pharmacology, Polish Academy of Sciences, Smętna 12, PL 31-343 Kraków, Poland. basta@if-pan.krakow.pl
Budziszewska
Bogusława
B
Leśkiewicz
Monika
M
Fijał
Katarzyna
K
Regulska
Magdalena
M
Kubera
Marta
M
Wędzony
Krzysztof
K
Lasoń
Władysław
W
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D014150:Antipsychotic Agents / Q000494:pharmacology*; D002746:Chlorpromazine / Q000494:pharmacology; D003024:Clozapine / Q000494:pharmacology*; D003345:Corticosterone / Q000097:blood; D005260:Female; D005625:Frontal Lobe / Q000187:drug effects / Q000378:metabolism; D006624:Hippocampus / Q000187:drug effects / Q000378:metabolism; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects* / Q000503:physiopathology; D008070:Lipopolysaccharides / Q000494:pharmacology; D008297:Male; D018811:Maternal Exposure; D008431:Maternal-Fetal Exchange; D009043:Motor Activity / Q000187:drug effects*; D010913:Pituitary-Adrenal System / Q000187:drug effects* / Q000503:physiopathology; D011247:Pregnancy; D051381:Rats; D017208:Rats, Wistar; D011965:Receptors, Glucocorticoid / Q000378:metabolism; D013216:Reflex, Startle / Q000187:drug effects*; D012559:Schizophrenia / Q000378:metabolism* / Q000503:physiopathology; D022021:Tacrolimus Binding Proteins / Q000378:metabolism; D000099159:Tacrolimus Binding Protein 5
D000661:Amphetamine; D014150:Antipsychotic Agents; D002746:Chlorpromazine; D003024:Clozapine; D003345:Corticosterone; D008070:Lipopolysaccharides; D011965:Receptors, Glucocorticoid; D022021:Tacrolimus Binding Proteins; D000099159:Tacrolimus Binding Protein 5